G Bompiani

539 total citations
41 papers, 433 citations indexed

About

G Bompiani is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, G Bompiani has authored 41 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Genetics and 13 papers in Surgery. Recurrent topics in G Bompiani's work include Diabetes and associated disorders (13 papers), Blood properties and coagulation (9 papers) and Diabetes Management and Research (8 papers). G Bompiani is often cited by papers focused on Diabetes and associated disorders (13 papers), Blood properties and coagulation (9 papers) and Diabetes Management and Research (8 papers). G Bompiani collaborates with scholars based in Italy. G Bompiani's co-authors include Rosamaria Cordova, Vincenzo Di Garbo, G Raneli, G Triolo, Carla Giordano, Aldo Galluzzo, Giuseppe Avellone, R. De Simone, Anna Maria Rinaldi and Graziella Rubino and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Journal of the American Geriatrics Society.

In The Last Decade

G Bompiani

39 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Bompiani Italy 13 148 131 90 88 79 41 433
S O Bohman Sweden 12 106 0.7× 182 1.4× 33 0.4× 129 1.5× 36 0.5× 18 676
A. M. De Bruyn Netherlands 9 230 1.6× 136 1.0× 296 3.3× 181 2.1× 71 0.9× 12 687
J. de Graeff Netherlands 16 96 0.6× 152 1.2× 38 0.4× 130 1.5× 67 0.8× 37 602
William J. Vicic United States 9 109 0.7× 101 0.8× 107 1.2× 87 1.0× 58 0.7× 12 606
Marco Morale Italy 8 88 0.6× 82 0.6× 153 1.7× 88 1.0× 97 1.2× 14 484
James A. Bougas United States 12 91 0.6× 74 0.6× 106 1.2× 121 1.4× 40 0.5× 19 444
José María Pou Spain 12 143 1.0× 94 0.7× 144 1.6× 36 0.4× 28 0.4× 22 376
Mauer Sm United States 13 102 0.7× 144 1.1× 18 0.2× 87 1.0× 44 0.6× 28 512
Marja Deckert Denmark 12 253 1.7× 60 0.5× 192 2.1× 76 0.9× 22 0.3× 18 691
Yekta Tüzün Türkiye 11 148 1.0× 110 0.8× 26 0.3× 43 0.5× 41 0.5× 21 403

Countries citing papers authored by G Bompiani

Since Specialization
Citations

This map shows the geographic impact of G Bompiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Bompiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Bompiani more than expected).

Fields of papers citing papers by G Bompiani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Bompiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Bompiani. The network helps show where G Bompiani may publish in the future.

Co-authorship network of co-authors of G Bompiani

This figure shows the co-authorship network connecting the top 25 collaborators of G Bompiani. A scholar is included among the top collaborators of G Bompiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Bompiani. G Bompiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avellone, Giuseppe, et al.. (1998). [Food habits and cardiovascular risk factors in 2 population samples of western Sicily].. PubMed. 12(4). 210–6. 3 indexed citations
2.
Garbo, Vincenzo Di, et al.. (1997). Effects of heparin treatment on hemostatic abnormalities in obese non—insulin-dependent diabetic patients. Metabolism. 46(8). 930–934. 7 indexed citations
3.
Garbo, Vincenzo Di, et al.. (1996). Activation of coagulation but normal fibrinolysis in patients with type IIa hyperlipoproteinemia. Thrombosis Research. 81(2). 277–282. 4 indexed citations
4.
Zanchetti, Alberto, Raffaele D’Ippolito, G Bompiani, et al.. (1995). Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: Efficacy and metabolic effects. 4(3). 38–46. 2 indexed citations
5.
Avellone, Giuseppe, Vincenzo Di Garbo, Rosamaria Cordova, et al.. (1995). Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia. Blood Coagulation & Fibrinolysis. 6(6). 543–548. 20 indexed citations
6.
Garbo, Vincenzo Di, et al.. (1994). Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution. Thrombosis Research. 75(3). 223–231. 32 indexed citations
7.
Avellone, Giuseppe, Vincenzo Di Garbo, Rosamaria Cordova, et al.. (1993). Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion. Blood Coagulation & Fibrinolysis. 4(3). 429–434. 17 indexed citations
8.
Avellone, Giuseppe, Vincenzo Di Garbo, Rosamaria Cordova, et al.. (1993). Fibrinolytic effect of gemfibrozil versus placebo administration in response to venous occlusion. Fibrinolysis and Proteolysis. 7(6). 416–421. 12 indexed citations
9.
Andronico, Giuseppe, et al.. (1992). Insulin resistance and endogenous digoxin-like factor in obese hypertensive patients with glucose intolerance. Acta Diabetologica. 28(3-4). 203–205. 10 indexed citations
10.
Triolo, G, et al.. (1991). Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor.. PubMed. 84(1). 53–8. 7 indexed citations
11.
Triolo, G, et al.. (1989). Serum Levels of Type III Procollagen Peptide in Diabetes Mellitus. Hormone and Metabolic Research. 21(2). 77–80. 3 indexed citations
12.
Triolo, G, et al.. (1989). Detection of anti-phospholipid (cardiolipin, phosphatidylserine) antibodies in the serum of patients with non insulin-dependent (type 2) diabetes mellitus and macroangiopathy. Coexistence of anti-platelet reactivity.. PubMed. 10(2). 63–7. 8 indexed citations
13.
Triolo, G, et al.. (1989). Cross-Reactivity of Anti-ssDNA Antibodies With Heparan Sulfate in Patients With Type I Diabetes Mellitus. Diabetes. 38(6). 718–722. 12 indexed citations
15.
Giordano, Carla, et al.. (1988). Increased soluble interleukin-2 receptor levels in the sera of type 1 diabetic patients.. PubMed. 8(3). 135–8. 38 indexed citations
16.
Bompiani, G, et al.. (1986). Treatment of non insulin-dependent diabetic women during pregnancy. European Journal of Endocrinology. 113(3_Suppl). S56–S59. 1 indexed citations
17.
Donatelli, M, et al.. (1984). Placental lactogen, progesterone, total estriol and prolactin plasma levels in pregnant women with insulin-dependent diabetes mellitus. European Journal of Obstetrics & Gynecology and Reproductive Biology. 16(6). 393–401. 17 indexed citations
18.
Galluzzo, Aldo, et al.. (1980). Leukocyte Migration Test in Subacute Thyroiditis: Hypothetical Role of Cell-Mediated Immunity*. The Journal of Clinical Endocrinology & Metabolism. 50(6). 1038–1041. 7 indexed citations
19.
Bompiani, G, et al.. (1968). Livelli serici di insulina nel soggetto normale (Obeso e non) e nel diabetico obeso Dopo Carico Intragastrico di Aminoacidi. Acta Diabetologica. 5(1). 64–79. 3 indexed citations
20.
Bompiani, G, et al.. (1968). Risposta insulo-secretrice al carico endovenoso di tolbutamide. Acta Diabetologica. 5(2). 187–200.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026